Late breaking trials of 2015 in coronary artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, ESC, and AHA

Catheter Cardiovasc Interv. 2016 Jun;87(7):1224-30. doi: 10.1002/ccd.26474. Epub 2016 Mar 4.

Abstract

The SCAI Publications Committee and Emerging Leadership Mentorship (ELM) Fellows concisely summarize and provide context on the most important coronary trials presented at large international meetings in 2015, including the MATRIX, ABSORB, and TOTAL trials. The intent is to allow quick assimilation of trial results into interventional practice, and enable busy interventional cardiologists to stay up to date. © 2016 Wiley Periodicals, Inc.

Keywords: antithrombotics; coronary physiology; myocardial infarction; review; stents.

MeSH terms

  • Cardiology*
  • Congresses as Topic
  • Coronary Artery Bypass*
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / physiopathology
  • Coronary Artery Disease / therapy*
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Percutaneous Coronary Intervention*
  • Randomized Controlled Trials as Topic*
  • Societies, Medical*
  • Treatment Outcome

Substances

  • Fibrinolytic Agents